What is Generation Lab?
Generation Lab offers a pioneering platform designed to quantify the efficacy of longevity interventions. Co-founded by Dr. Irina Conboy, a distinguished aging and longevity researcher from UC Berkeley, the company utilizes an accessible testing methodology coupled with proprietary techniques. These methods precisely measure molecular imbalances indicative of aging and potential disease onset, even before symptoms manifest. Clinicians leverage Generation Lab's insights to guide personalized interventions aimed at enhancing health, wellness, and lifespan, with the platform uniquely tracking the effectiveness of these treatments over time.
How much funding has Generation Lab raised?
Generation Lab has raised a total of $11M across 1 funding round:
Seed
$11M
Seed (2025): $11M with participation from Samsung NEXT and Accel
Key Investors in Generation Lab
Samsung NEXT
Samsung NEXT is a venture capital arm focused on software and services, aiming to complement Samsung's hardware ecosystem through investment and product development.
Accel
Accel is a global venture capital firm that supports exceptional teams from early-stage ideas through all phases of private company growth, focusing on innovative companies and entrepreneurs.
What's next for Generation Lab?
The recent major strategic investment signals a pivotal growth phase for Generation Lab, likely enabling the company to scale its operations, expand its research and development capabilities, and broaden its market reach. This capital infusion is expected to accelerate the adoption of its unique aging assessment technology by clinicians, further solidifying its position as a leader in the proactive health and longevity market. The company's focus on measurable outcomes for longevity interventions positions it for significant future expansion and impact.
See full Generation Lab company page
